STAT+: Pharmalittle: Amgen agrees to pay $27.8 billion for Horizon Therapeutics; Roche pharma head steps down
Amgen's planned purchase of Horizon Pharmaceuticals marks the latest bet by a large drug company on the lucrative market for treating a rare disease.
